[1]
“Development and Characterization of a Combination Tablet Dosage Form Containing Sofosbuvir and Ribavirin Using Design of Experiments (DoE) Approach”, Dhaka Univ. J. Pharm. Sci, vol. 20, no. 1, pp. 121–133, Jun. 2021, doi: 10.3329/dujps.v20i1.54040.